Azole Antifungal Susceptibility Testing of Candida Species Using E test / 대한피부과학회지
Korean Journal of Dermatology
;
: 654-659, 2001.
Artigo
em Coreano
| WPRIM
| ID: wpr-177504
ABSTRACT
BACKGROUND:
Because of recently increasing reports of azole-resistant Candida species, it is necessary to perform antifungal susceptibility test. E test(AB Biodisk, Sweden) is a rapid, easy-to- perform in-vitro antifungal susceptibility test.OBJECTIVE:
The purpose of the study was to investigate the minimal inhibitory concentration(MIC) of azole antifungal agents against Candida sp. isolated from skin lesion using E test.METHODS:
Twenty-seven clinical isolates of Candida sp.(including 24 C. albicans, 2 C. parapsilosis, and 1 C. guilliermondii) were tested. MIC endpoints of E test for itraconazole(ICZ) and fluconazole (FCZ) susceptibility were read after 24 hours for each isolates on Casitone agar.RESULTS:
MIC of azole antifungal agents against Candida sp. MIC of ICZ was 0.008-1.0microgram/mL on C. albicans, 0.023-0.125microgram/mL on C. parapsilosis, and 0.064microgram/mL on C. guilliermondii. MIC of FCZ was 0.5-4.0microgram/mL on C. albicans, 1.5-2.0microgram/mL on C. parapsilosis, and 0.5microgram/mL on C. guilliermondii. According to NCCLS(National Committee for Clinical Laboratory Standards) guidelines, two strains of C. albicans isolated from patients with Candidal intertrigo showed ICZ-resistant.CONCLUSION:
We found that E test represented a simple and valuable method for susceptibility test for Candida sp.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pele
/
Candida
/
Fluconazol
/
Danazol
/
Ágar
/
Intertrigo
/
Antifúngicos
Tipo de estudo:
Guia de Prática Clínica
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Ano de publicação:
2001
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS